TrialAdvances in therapy2022

Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.

Yuji Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.